Barclays’s Absci ABSI Stock Holding History

Barclays’s Portfolio ABSI Stock Details ABSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$712K	Buy	+61,400	New	+$346K	﹤0.01%	2997

Other funds holding ABSI

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AMD

Advanced Micro Devices Santa Clara, California $1.31B AUM

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Barclays's ABSI Position: Q2 2026 in Review

Barclays reduced its Absci (ABSI) stake by 18% in Q2 2026, selling an estimated $81.5K and leaving 68,058 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #2939.

Barclays first reported a position in ABSI in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.78M in Q4 2025. 197 funds tracked by Wall St. Rank hold ABSI as of Q2 2026.

Barclays held 68,058 shares of Absci worth $789K as of Q2 2026.
Barclays sold 14,465 Absci shares in Q2 2026, an estimated $81.5K.
Absci made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2939 holding.
Barclays first reported a position in Absci in Q1 2022 and has held it in 18 quarters since.
Barclays's Absci position peaked at $1.78M in Q4 2025.
197 funds tracked by Wall St. Rank held Absci as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.